Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone
- 10 July 2001
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 14 (1) , 47-52
- https://doi.org/10.1016/s0928-0987(01)00144-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Sensitive and specific high-performance liquid chromatographic assay for 4′-hydroxyflurbiprofen and flurbiprofen in human urine and plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Nonspecific binding of drugs to human liver microsomesBritish Journal of Clinical Pharmacology, 2000
- Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active SitesBiochemistry, 1998
- N‐Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.British Journal of Clinical Pharmacology, 1995
- Biochemistry and molecular biology of the human CYP2C subfamilyPharmacogenetics, 1994
- The disposition of dapsone in cirrhosisClinical Pharmacology & Therapeutics, 1992
- Stereoselective disposition of flurbiprofen in normal volunteers.Published by Wiley ,1992
- High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- The Disposition and Metabolism of Flurbiprofen in Several Species Including ManXenobiotica, 1978
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971